CENTRE MEDICAL MULTITUDE: what changed
What changed
CENTRE MEDICAL MULTITUDE
filed annual accounts (NBB)
Net result for the year
-€16,180
2024 · -€40,267+€24,087
Equity
€91,676
2024 · €107,857-€16,180
Cash
€19,616
2024 · €40,294-€20,678
Balance sheet total
€1.8m
2024 · €1.4m+€428,346
Largest movements
Assets
- Tangible fixed assets +€447,951
up €447,951 (+33.8%), from €1.3m to €1.8m
of which Land and buildings: +€413,717
- Cash -€20,678
down €20,678 (-51.3%), from €40,294 to €19,616
mainly Investment in fixed assets (net) (-€523,201) and Net result for the year (-€16,180)
Equity and liabilities
- Debts after one year +€418,131
up €418,131 (+33.3%), from €1.3m to €1.7m
- Current portion of long-term debt +€24,875
new in 2025: €24,875
Income statement
- Gross operating margin +€90,863
up €90,863 (+404%), from €22,484 to €113,347
- Depreciation +€39,304
up €39,304 (+109%), from €35,946 to €75,250
- Financial charges +€27,147
up €27,147 (+103%), from €26,303 to €53,451
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
-€40,267
Gross operating margin
+€90,863
Depreciation
-€39,304
Other operating charges
-€366
Financial income
+€41
Financial charges
-€27,147
Result 2025
-€16,180
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€59,517
Investment
-€523,201
Financing
+€443,006
Cash 2024
€40,294
From operations (derived)
+€59,517
Net result for the year
-€16,180
Depreciation
+€75,250
Smaller working-capital items
-€952
Accrued charges and deferred income
+€1,400
Investment (derived)
-€523,201
Investment in fixed assets (net)
-€523,201
Financing
+€443,006
Debts after one year
+€418,131
Current portion of long-term debt
+€24,875
Cash 2025
€19,616
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,365,341 | €1,793,687 | +€428,346 | +31.4% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €1,324,268 | €1,772,220 | +€447,951 | +33.8% |
| Tangible fixed assets | 22/27 | €1,324,268 | €1,772,220 | +€447,951 | +33.8% |
| Land and buildings | 22 | €1,324,268 | €1,737,985 | +€413,717 | +31.2% |
| Furniture and vehicles | 24 | - | €34,234 | +€34,234 | |
| Current assets | 29/58 | €41,073 | €21,468 | -€19,605 | -47.7% |
| Amounts receivable within one year | 40/41 | - | €12 | +€12 | |
| Other amounts receivable | 41 | - | €12 | +€12 | |
| Cash at bank and in hand | 54/58 | €40,294 | €19,616 | -€20,678 | -51.3% |
| Deferred charges and accrued income | 490/1 | €778 | €1,839 | +€1,061 | +136% |
| Total equity and liabilities | 10/49 | €1,365,341 | €1,793,687 | +€428,346 | +31.4% |
| Equity | 10/15 | €107,857 | €91,676 | -€16,180 | -15.0% |
| Contributions | 10/11 | €150,000 | €150,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€42,143 | -€58,324 | -€16,180 | -38.4% |
| Amounts payable | 17/49 | €1,257,484 | €1,702,011 | +€444,527 | +35.4% |
| Amounts payable after more than one year | 17 | €1,256,994 | €1,675,125 | +€418,131 | +33.3% |
| Financial debts | 170/4 | €1,256,994 | €1,675,125 | +€418,131 | +33.3% |
| Amounts payable within one year | 42/48 | €490 | €25,486 | +€24,996 | +5,101% |
| Current portion of amounts payable after more than one year | 42 | - | €24,875 | +€24,875 | |
| Trade debts | 44 | €490 | €611 | +€121 | +24.7% |
| Suppliers | 440/4 | €490 | €611 | +€121 | +24.7% |
| Accrued charges and deferred income | 492/3 | - | €1,400 | +€1,400 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €35,946 | €75,250 | +€39,304 | +109% |
| Other operating charges | 640/8 | €502 | €868 | +€366 | +72.8% |
| Gross operating margin | 9900 | €22,484 | €113,347 | +€90,863 | +404% |
| Operating profit (loss) | 9901 | -€13,964 | €37,229 | +€51,193 | |
| Financial income | 75/76B | - | €41 | +€41 | |
| Recurring financial income | 75 | - | €41 | +€41 | |
| Financial charges | 65/66B | €26,303 | €53,451 | +€27,147 | +103% |
| Recurring financial charges | 65 | €26,303 | €53,451 | +€27,147 | +103% |
| Profit (loss) for the period before taxes | 9903 | -€40,267 | -€16,180 | +€24,087 | +59.8% |
| Income taxes | 67/77 | - | €0 | = | |
| Profit (loss) for the period | 9904 | -€40,267 | -€16,180 | +€24,087 | +59.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€40,267 | -€16,180 | +€24,087 | +59.8% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.